Details on surprise Novartis heart drug success due Aug 27
Reuters: Health News
LONDON (Reuters) - Full details on the surprise success of a Novartis anti-inflammatory drug in cutting cardiovascular risk for heart attack survivors will be presented at a medical meeting on Aug. 27, conference organizers said on Thursday.
LONDON (Reuters) - AstraZeneca and Hutchison China MediTech said on Thursday they had initiated a global late-stage clinical trial of the experimental drug savolitinib in a relatively rare type of kidney cancer.
CLEVELAND (Reuters) - Ohio's Republican-controlled legislature voted on Wednesday to freeze enrollment in the state's Medicaid healthcare insurance for the poor, setting the stage for a showdown with Republican Governor John Kasich, who favors expanding the program.
SHANGHAI (Reuters) - China will push to diversify how it pays the healthcare costs for its nearly 1.4 billion people in a bid to stem "irrational growth" of medical costs, the finance ministry said in a statement on Thursday.
No comments:
Post a Comment